Clinical Trial: A Study to Investigate the Transition of Children From 'Artisanal" Cannabidiol (CBD) to Epidiolex

U.S., April 12 -- ClinicalTrials.gov registry received information related to the study (NCT06924827) titled 'A Study to Investigate the Transition of Children From 'Artisanal" Cannabidiol (CBD) to Epidiolex' on April 04.

Brief Summary: The goal of this clinical trial is to learn the best way to switch children with Lennox-Gastaut Syndrome (LGS) or Dravet Syndrome (DS) taking 'artisanal' (non pharmaceutical-grade) cannabidiol (CBD) to Epidiolex for treatment of seizures. The main questions it aims to answer are:

* How well does a gradual switch from 'artisanal' CBD to Epidiolex work?

* Does the same dose of Epidiolex as 'artisanal' CBD work best?

* What side-effects or medical problems do participants have when switching from 'artisanal...